| Literature DB >> 32004987 |
Giorgia Bruno1, Gianfranco Puoti2, Mariano Oliva2, Davide Colavito2, Lia Allegorico2, Filomena Napolitano2, Simone Sampaolo2.
Abstract
Caveolins are essential proteins in caveolae architecture, small plasma membrane invaginations that play a key role in a variety of cellular processes, including vesicular trafficking and signal transduction. Mutations in the gene encoding caveolin-3 (CAV3) cause a broad spectrum of clinical phenotypes, ranging from isolated hyperCKemia to most severe limb girdle muscular dystrophy and cardiomyopathy. We report a novel heterozygous p.Val44Met (c.130G > A) CAV3 mutation in two brothers presenting with persistent elevation of serum creatine kinase, myalgia and hypercholesterolemia. Immunofluorescence study with anticaveolin-3 antibodies on muscle biopsy of the proband confirmed a reduced immuno-reactivity of caveolin-3 on the sarcolemma. This findings support the pathogenic effect of this novel mutation and extend the genotypic and clinical spectrum of Caveolinopathies. Finally, we discuss the hypothesis that the association between CAV3 mutations and hypercholesterolemia may not be coincidental.Entities:
Keywords: Caveolin-3; Caveolinopathy; Creatine kinase; Genetic diseases; Hypercholesterolemia; Muscular diseases; Myalgia
Mesh:
Substances:
Year: 2020 PMID: 32004987 DOI: 10.1016/j.clineuro.2020.105687
Source DB: PubMed Journal: Clin Neurol Neurosurg ISSN: 0303-8467 Impact factor: 1.876